A citation-based method for searching scientific literature

Mehryar Taban, David S Boyer, Edgar L Thomas, Mehran Taban. Am J Ophthalmol 2004
Times Cited: 132



Felice Cardillo Piccolino, Roberta Rigault de la Longrais, Giambattista Ravera, Chiara M Eandi, Luca Ventre, Ali' Abdollahi, Marilisa Manea. Am J Ophthalmol 2005
Times Cited: 234




List of shared articles



Times cited

Evaluation of the choriocapillaris after photodynamic therapy for chronic central serous chorioretinopathy. A review of optical coherence tomography angiography (OCT-A) studies.
Evita Evangelia Christou, Panagiotis Stavrakas, Vassilios Kozobolis, Andreas Katsanos, Ilias Georgalas, Maria Stefaniotou. Graefes Arch Clin Exp Ophthalmol 2022
5

Evaluation of the choroidal vascularity index after subthreshold yellow laser treatment in the patients with chronic central serous chorioretinopathy.
Sema Tamer Kaderli, Aylin Karalezli, Ahmet Kaderli, Simay Can Taskin, Sabahattin Sul. Eye (Lond) 2022
0


Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy.
Sónia Torres-Costa, Susana Penas, Ana Rita Cerqueira, Elisete Brandão, Ângela Carneiro, Amândio Rocha-Sousa, Fernando Falcão-Reis. Photodiagnosis Photodyn Ther 2021
3





A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial.
Mingwei Zhao, Feng Zhang, Youxin Chen, Hong Dai, Jinfeng Qu, Chongya Dong, Xiaoping Kang, Yuling Liu, Liu Yang, Yibin Li,[...]. JAMA Ophthalmol 2015
42

Quantification of metamorphopsia in chronic central serous chorioretinopathy after half-dose verteporfin photodynamic therapy.
Kyoko Fujita, Yutaka Imamura, Kei Shinoda, Celso Soiti Matsumoto, Yoshihiro Mizutani, Atsushi Mizota, Mitsuko Yuzawa. Retina 2014
16

Half-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Chun-Fu Liu, Lee-Jen Chen, Shawn H Tsai, Chi-Chun Lai, Wei-Chun Chan, Wei-Chi Wu, Nan-Kai Wang, Kuan-Jen Chen, Yih-Shiou Hwang, Yen-Po Chen,[...]. J Ocul Pharmacol Ther 2014
12

Central serous chorioretinopathy: a review of epidemiology and pathophysiology.
Gerald Liew, Godfrey Quin, Mark Gillies, Samantha Fraser-Bell. Clin Exp Ophthalmol 2013
243

Early changes in foveal thickness in eyes with central serous chorioretinopathy.
Masayuki Hata, Akio Oishi, Masataka Shimozono, Michiko Mandai, Akihiro Nishida, Yasuo Kurimoto. Retina 2013
35

Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.
Helena Vasconcelos, Inês Marques, A Rita Santos, Pedro Melo, Isabel Pires, João Figueira, José Faria de Abreu, M Luz Cachulo, Rufino Silva. Graefes Arch Clin Exp Ophthalmol 2013
38

Central serous chorioretinopathy: update on pathophysiology and treatment.
Benjamin Nicholson, Jason Noble, Farzin Forooghian, Catherine Meyerle. Surv Ophthalmol 2013
371

One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis.
Yasuhiro Ohkuma, Takaaki Hayashi, Tsutomu Sakai, Akira Watanabe, Hiroshi Tsuneoka. Graefes Arch Clin Exp Ophthalmol 2013
27



Graded subthreshold transpupillary thermotherapy for chronic central serous chorioretinopathy.
George J Manayath, Venkatapathy Narendran, Saurabh Arora, Rodney J Morris, Veerappan R Saravanan, Parag K Shah. Ophthalmic Surg Lasers Imaging 2012
7

Photodynamic therapy and central serous chorioretinopathy.
Lina Siaudvytyte, Vaida Diliene, Goda Miniauskiene, Vilma Jurate Balciuniene. Med Hypothesis Discov Innov Ophthalmol 2012
9



Factors influencing the visual acuity of chronic central serous chorioretinopathy.
Yun Young Kim, Christina J Flaxel. Korean J Ophthalmol 2011
18